Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
Authors:
- Ryota SakuraiRSRyota Sakurai
- Frederico Pieruccini‐FariaFPFrederico Pieruccini‐Faria
- Benjamin CornishBCBenjamin Cornish
- Malcolm A. BinnsMBMalcolm A. Binns
- Derek BeatonDBDerek Beaton
- Allison Ann DilliottADAllison Ann Dilliott
- Donna KwanDKDonna Kwan
- Joel RamirezJRJoel Ramirez
- Brian TanBTBrian Tan
- Kelly M. SunderlandKSKelly M. Sunderland
Open Access
- 12 March 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (4) , 2968-2979
Abstract
INTRODUCTION: Apolipoprotein E E4 allele (APOE E4) and slow gait are independently associated with cognitive impairment and dementia. However, it is unknown whether their coexistence is associated with poorer cognitive performance and its underlying mechanism in neurodegenerative diseases.METHODS: Gait speed, APOE E4, cognition, and neuroimaging were assessed in 480 older adults with neurodegeneration. Participants were grouped by APOE E4 presence and slow gait. Mediation analyses were conducted to determine if brain structures could explain the link between these factors and cognitive performance.RESULTS: APOE E4 carriers with slow gait had the lowest global cognitive performance and smaller gray matter volumes compared to non‐APOE E4 carriers with normal gait. Coexistence of APOE E4 and slow gait best predicted global and domain‐specific poorer cognitive performances, mediated by smaller gray matter volume.DISCUSSION: Gait slowness in APOE E4 carriers with neurodegenerative diseases may indicate extensive gray matter changes associated with poor cognition.Highlights: APOE E4 and slow gait are risk factors for cognitive decline in neurodegenerative diseases. Slow gait and smaller gray matter volumes are associated, independently of APOE E4. Worse cognition in APOE E4 carriers with slow gait is explained by smaller GM volume. Gait slowness in APOE E4 carriers indicates poorer cognition‐related brain changes.Keywords
Funding Information
- Centre for Addiction and Mental Health Foundation
- London Health Sciences Foundation
- Faculty of Health Sciences, Queen's University
- Temerty Family Foundation
This publication has 69 references indexed in Scilit:
- Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortAlzheimer's & Dementia, 2022
- CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensusAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid‐β copathologyAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019
- Cerebrovascular Effects of Apolipoprotein EJAMA Neurology, 2013
- Neurodegeneration Across Stages of Cognitive Decline in Parkinson DiseaseArchives of Neurology, 2011
- Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3TJournal of Magnetic Resonance Imaging, 2010
- Bradypedia: Is gait speed ready for clinical use?The Journal of nutrition, health and aging, 2009
- Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesionsAnnals of Neurology, 2004
- A Robust Method for Extraction and Automatic Segmentation of Brain ImagesNeuroImage, 2002
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997